Technical Analysis for OBMP - Oncbiomune Pharmaceuticals Inc.

Grade Last Price % Change Price Change
grade B 0.325 -14.47% -0.0550
OBMP closed down 14.47 percent on Tuesday, June 30, 2020, on 1.51 times normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Very Strong Up Up Up
Historical OBMP trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
Stochastic Buy Signal Bullish 0.00%
1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Outside Day Range Expansion 0.00%
Wide Bands Range Expansion 0.00%
1,2,3 Pullback Bullish Bullish Swing Setup -14.47%
Boomer Buy Setup Bullish Swing Setup -14.47%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -14.47%
Narrow Range Bar Range Contraction -14.47%
Older signals for OBMP ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


OncBioMune Pharmaceuticals, Inc. is a clinical-stage biotechnology company. The Company specializes in various cancer therapies. The Company focuses on developing breast and prostate cancer therapeutic vaccines, and a process for the growth of cancer cells and targeted chemotherapies. Its product portfolio consists of approximately three target therapies and a vaccine platform. The Company's lead product, ProscaVax is indicated for prostate cancer. Its focuses on planning Phase II clinical trials of ProscaVax. The Company is also focused on development of its other technologies, such as the paclitaxel-albumin conjugate. It also has a portfolio of targeted therapies, some of which are biosimilars to drugs, including paclitaxel (Abraxane). The Company is focused on the tumor specific immune status of patients both pre and post immunotherapy that uses autologous tumor antigens to immunize patients. The Company focuses on offering Bekunis for constipation and Cirkused for stress.
Medicine Biotechnology RTT Cancer Organic Compounds Chemotherapy Oncology Immunotherapy Prostate Cancer Tumor Antineoplastic Drugs Constipation Targeted Therapy Cancer Therapies Breast And Prostate Cancer Chemotherapies

Is OBMP a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 1.25
52 Week Low 0.0021
Average Volume 8,085
200-Day Moving Average 0.1294
50-Day Moving Average 0.2058
20-Day Moving Average 0.3455
10-Day Moving Average 0.3205
Average True Range 0.1496
ADX 53.48
+DI 44.5659
-DI 10.9923
Chandelier Exit (Long, 3 ATRs ) 0.8012
Chandelier Exit (Short, 3 ATRs ) 0.5488
Upper Bollinger Band 0.7913
Lower Bollinger Band -0.1003
Percent B (%b) 0.48
BandWidth 258.0608
MACD Line 0.0390
MACD Signal Line 0.0443
MACD Histogram -0.0052
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.5050
Resistance 3 (R3) 0.5167 0.4683 0.4750
Resistance 2 (R2) 0.4683 0.4225 0.4625 0.4650
Resistance 1 (R1) 0.3967 0.3942 0.3725 0.3850 0.4550
Pivot Point 0.3483 0.3483 0.3363 0.3425 0.3483
Support 1 (S1) 0.2767 0.3025 0.2525 0.2650 0.1950
Support 2 (S2) 0.2283 0.2742 0.2225 0.1850
Support 3 (S3) 0.1567 0.2283 0.1750
Support 4 (S4) 0.1450